Clear Creek Financial Management’s GSK GSK Stock Holding History

Clear Creek Financial Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$273K	Buy	4,953 +1	+0%	+$54	0.02%	520
2025 Q4	$243K	Buy	+4,952	New	+$231K	0.02%	522

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Clear Creek Financial Management's GSK Position: Q1 2026 in Review

Clear Creek Financial Management increased its GSK (GSK) stake by 0.02% in Q1 2026, buying an estimated $54 and bringing the position to 4,953 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #520.

Clear Creek Financial Management first reported a position in GSK in Q4 2025 and has held it in 2 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Clear Creek Financial Management held 4,953 shares of GSK worth $273K as of Q1 2026.
Clear Creek Financial Management bought 1 GSK share in Q1 2026, an estimated $54.
GSK made up 0.02% of Clear Creek Financial Management's portfolio in Q1 2026, its #520 holding.
Clear Creek Financial Management first reported a position in GSK in Q4 2025 and has held it in 2 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Clear Creek Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.